Lonchocarpus haberi
Lonchocarpus haberi · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Lonchocarpus haberi is a specialized plant species that has garnered significant interest within the field of pharmacological research. Scientific investigations into its chemical composition have revealed a unique profile of secondary metabolites. Most notably, studies have demonstrated that the plant exhibits potent cytotoxic activities against various cell lines. These biological properties suggest that its extracts may hold potential for future development in cancer therapeutics. Understanding the underlying mechanisms of these effects remains a primary focus for researchers studying this species.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Lonchocarpus haberi is a distinctive plant species known more commonly by its regional name, the Chaperno. This botanical specimen holds a unique place in its ecosystem, bridging the gap between scientific classification and local vernacular. By understanding its common identity, researchers and nature enthusiasts can better document its specific environmental needs. The relationship between its formal Latin designation and the name Chaperno highlights the deep connection between scientific study and traditional knowledge. Ultimately, recognizing both names ensures that this important plant receives the attention it deserves in both academic and local contexts.
Sources: Catalogue of Life (COL)
Taxonomy
Lonchocarpus haberi is a fascinating botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further resides in the order Fabales, a group that highlights its unique evolutionary lineage. As a member of the family Fabaceae, it shares important characteristics with many well-known legumes. Finally, it is categorized under the specific genus Lonchocarpus, completing its detailed taxonomic profile.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Lonchocarpus |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Lonchocarpus haberi is a distinctive plant species found primarily across the diverse landscapes of Southern America. Its natural range extends northward through the lush terrains of Central America, showcasing its adaptability to tropical environments. Within these regions, Costa Rica serves as a significant habitat where the species can be observed flourishing. This wide distribution highlights the plant's ecological importance throughout the Neotropical zone. Understanding its geographic presence provides valuable insights into the botanical richness of these interconnected territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Lonchocarpus haberi is characterized by its distinct tree-like growth form. As a self-supporting species, it maintains its structural integrity without the need for external climbers or scaffolds.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Lonchocarpus haberi contains specific prenylated flavonoids that demonstrate significant cytotoxic activity. Recent molecular docking investigations have explored how these compounds interact with various cancer-relevant biochemical targets. By utilizing programs such as Molegro and ArgusDock, researchers compared the binding energies of these flavonoids against several key enzymes. The results indicate that these flavonoids exhibit inhibitory potential comparable to, or even stronger than, previously known effective inhibitors. Ultimately, it is suggested that the plant's cytotoxic properties may stem from the inhibition of one or more of these critical enzymatic pathways.
Compounds
Conditions
Lonchocarpus haberi contains cytotoxic prenylated flavonoids that interact with several cancer-relevant biochemical targets. These flavonoids demonstrate significant binding potential toward the ATP binding cassette (ABC) transporter. Molecular docking analysis further indicates that these compounds effectively target aromatase (CYP 19). Additionally, the plant's flavonoids show a capacity to treat cyclooxygenases (COX-1 and COX-2). The research also highlights their ability to inhibit fatty acid synthase (FAS) and lipoxygenase (LOX-3).